Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats

Acta Pharmacol Sin. 2021 Dec;42(12):2094-2105. doi: 10.1038/s41401-021-00622-7. Epub 2021 Mar 8.

Abstract

Aristolochic acid I (AAI) is a well-known nephrotoxic carcinogen, which is currently reported to be also associated with hepatocellular carcinoma (HCC). Whether AAI is a direct hepatocarcinogen remains controversial. In this study we investigated the association between AAI exposure and HCC in adult rats using a sensitive rat liver bioassay with several cofactors. Formation of glutathione S-transferase placental form-positive (GST-P+) foci was used as the marker for preneoplastic lesions/clonal expansion. We first conducted a medium-term (8 weeks) study to investigate whether AAI had any tumor-initiating or -promoting activity. Then a long-term (52 weeks) study was conducted to determine whether AAI can directly induce HCC. We showed that oral administration of single dose of AAI (20, 50, or 100 mg/kg) in combination with partial hepatectomy (PH) to stimulate liver proliferation did not induce typical GST-P+ foci in liver. In the 8-week study, only high dose of AAI (10 mg · kg-1 · d-1, 5 days a week for 6 weeks) in combination with PH significantly increased the number and area of GST-P+ foci initiated by diethylnitrosamine (DEN) in liver. Similarly, only high dose of AAI (10 mg· kg-1· d-1, 5 days a week for 52 weeks) in combination with PH significantly increased the number and area of hepatic GST-P+ foci in the 52-week study. No any nodules or HCC were observed in liver of any AAI-treated groups. In contrast, long-term administration of AAI (0.1, 1, 10 mg· kg-1· d-1) time- and dose-dependently caused death due to the occurrence of cancers in the forestomach, intestine, and/or kidney. Besides, AAI-DNA adducts accumulated in the forestomach, kidney, and liver in a time- and dose-dependent manner. Taken together, AAI promotes clonal expansion only in the high-dose group but did not induce any nodules or HCC in liver of adult rats till their deaths caused by cancers developed in the forestomach, intestine, and/or kidney. Findings from our animal studies will pave the way for further large-scale epidemiological investigation of the associations between AA and HCC.

Keywords: DNA adducts; aristolochic acid I; clonal expansion; glutathione S-transferase placental form-positive foci; hepatocellular carcinoma; medium-term rat liver bioassay.

MeSH terms

  • Animals
  • Aristolochic Acids / toxicity*
  • Carcinogenesis / drug effects
  • Carcinogens / toxicity*
  • Carcinoma, Hepatocellular / etiology*
  • Cell Proliferation / drug effects
  • DNA Adducts / drug effects
  • Glutathione S-Transferase pi / metabolism
  • Hepatocytes / metabolism*
  • Intestinal Neoplasms / chemically induced
  • Intestines / pathology
  • Kidney / pathology
  • Kidney Neoplasms / chemically induced
  • Liver / metabolism
  • Liver / pathology
  • Liver Neoplasms / etiology*
  • Male
  • Mutagens / toxicity*
  • Rats
  • Rats, Sprague-Dawley
  • Stomach / pathology
  • Stomach Neoplasms / chemically induced

Substances

  • Aristolochic Acids
  • Carcinogens
  • DNA Adducts
  • Mutagens
  • aristolochic acid I
  • Glutathione S-Transferase pi
  • Gstp1 protein, rat